Article Text

Download PDFPDF
Thromboembolic venous disease
Acute and long term management of pulmonary embolism

Statistics from


  • Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. The author reports serving as a consultant for Actelion, Bayer Schering, Eli Lilly, GlaxoSmithKline; and has received research and/or lecturing honoraria from Actelion, Bayer Schering, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Sanofi Aventis and Pfizer.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.